|
Gastrointestinal Research Studies
PANCREATIC
R0848 Phase
III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for
Patients with Resected Head of Pancreas Adenocarcinoma
COLORECTAL
E7208 A Randomized
Phase II Study of Irinotecan and Cetuximab with or without the Anti-Angiogenic
Antibody, Ramucirumab (IMC-1121B), in Advanced, K-ras Wild-type Colorectal
Cancer Following Progression on Bevacizumab-Containing Chemotherapy (temporarily
suspended)
MORAb-004-202 A Randomized,
Double-Blind Study of the Efficacy and Safety of Monotherapy MORAb-004 Plus Best
Supportive Care in Subjects with Chemorefractory Metastatic Colorectal Cancer (temporarily
suspended)
RECTAL
N1048 A Phase II/III
Trial of Neoadjuvant FOLFOX with Selective Use of Combined Modality
Chemoradiation Vs Preoperative Combined Modality Chemoradiation for Locally
Advanced Rectal Cancer Patients Undergoing Low Anterior Resection with Total
Mesorectal Excision
ESOPHAGEAL
R1010
A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality
Treatment of HER2-Overexpressing Esophageal Adenocarcinoma
ADJUVANT COLON
C80702 A Phase III Trial
of 6 Versus 12 Treatment of Adjuvant FOLFOX Plus Celecoxib or Placebo for
Patients with Resected Stage III Colon Cancer
CANCER CONTROL
P-5 Statin
Polyp Prevention Trial in Patients with Resected Colon Cancer
WFU-99311 Randomized
Placebo-Controlled Phase 2 Pilot Study of Memantine (Namenda) for Smoking
Cessation Among Cancer Survivors
|